BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23060065)

  • 1. Value of PAX2 immunostaining in tumor diagnosis: a review and update.
    Ordóñez NG
    Adv Anat Pathol; 2012 Nov; 19(6):401-9. PubMed ID: 23060065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of PAX 8 immunostaining in tumor diagnosis: a review and update.
    Ordóñez NG
    Adv Anat Pathol; 2012 May; 19(3):140-51. PubMed ID: 22498579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
    Tong GX; Memeo L; Colarossi C; Hamele-Bena D; Magi-Galluzzi C; Zhou M; Lagana SM; Harik L; Oliver-Krasinski JM; Mansukhani M; Falcone L; Hibshoosh H; O'Toole K
    Am J Surg Pathol; 2011 Oct; 35(10):1473-83. PubMed ID: 21934480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of paired box genes 8 and 2 expression in epithelium tissues and the related tumors].
    Song Y; Huang X; Shen GH; Liu XY; Zhang X
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):424-428. PubMed ID: 28635231
    [No Abstract]   [Full Text] [Related]  

  • 5. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
    Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
    Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX2 expression in Wilms tumors and other childhood neoplasms.
    Davis JL; Matsumura L; Weeks DA; Troxell ML
    Am J Surg Pathol; 2011 Aug; 35(8):1186-94. PubMed ID: 21730820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTF-1 expression in ovarian and uterine epithelial neoplasia and its potential significance, an immunohistochemical assessment with multiple monoclonal antibodies and different secondary detection systems.
    Zhang PJ; Gao HG; Pasha TL; Litzky L; Livolsi VA
    Int J Gynecol Pathol; 2009 Jan; 28(1):10-8. PubMed ID: 19047914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAX immunoreactivity in poorly differentiated small round cell tumors of childhood.
    Fan R
    Fetal Pediatr Pathol; 2014 Aug; 33(4):244-52. PubMed ID: 24897005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia.
    Quick CM; Laury AR; Monte NM; Mutter GL
    Am J Clin Pathol; 2012 Nov; 138(5):678-84. PubMed ID: 23086768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX2 and PAX8 expression in primary and metastatic müllerian epithelial tumors: a comprehensive comparison.
    Ozcan A; Liles N; Coffey D; Shen SS; Truong LD
    Am J Surg Pathol; 2011 Dec; 35(12):1837-47. PubMed ID: 21989345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
    Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
    Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
    Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of PAX8 and PAX2 immunohistochemistry in the identification of renal cell carcinoma in diagnostic cytology.
    Knoepp SM; Kunju LP; Roh MH
    Diagn Cytopathol; 2012 Aug; 40(8):667-72. PubMed ID: 22807381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
    Wiseman W; Michael CW; Roh MH
    Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA; Sharma R; Illei PB
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
    Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
    Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of Pax-2 as an immunohistochemical marker for renal cell carcinoma in cytopathology.
    Gokden N; Kemp SA; Gokden M
    Diagn Cytopathol; 2008 Jul; 36(7):473-7. PubMed ID: 18528893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall.
    McDaniel AS; Palanisamy N; Smith SC; Robinson DR; Wu YM; Chinnaiyan AM; McHugh JB; Greenson JK; Kunju LP
    Histol Histopathol; 2016 Feb; 31(2):223-30. PubMed ID: 26404914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L; Crumley S; Truong L; Mody D; Coffey D
    Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.